WHO WE ARE
We are a Norwegian biotechnology company focused on developing, manufacturing and marketing premium ingredients extracted from herring roe.
OUR MISSION
Our mission is to provide people with unique nutraceutical and pharmaceutical products based on herring roe.
WHERE WE WORK
We are based on the west coast of Norway. This gives us direct access to our raw material: - roe from spring-spawning herring caught in sustainable and certified fisheries.
Innovative products
Arctic Bioscience is a Norwegian biotechnology company developing products the world has never seen before. Located in Ørsta on the west coast of Norway, the Arctic Bioscience team has developed marine extracts for nutraceutical and pharmaceutical applications for over 30 years.
Nutraceutical
Products, Brands & Bulk
The brand name Romega is given to our exclusive Arctic Herring Caviar products. Our portfolio consists of high DHA marine Omega-3 phospholipid extracts and proteins derived from herring roe.
Pharmaceutical
Science is the foundation of our business. Arctic Bioscience has long experience in product development and is dedicated to conducting research and providing scientific evidence to document our products.
Production
We develop products, solutions, and technologies based on bioactive marine compounds from herring roe. The roe is sourced from Norwegian spring-spawning herring harvested by local MSC-certified fisheries.
High-DHA phospholipid extract from sustainable herring roe
On a mission to make Norway a sustainability pioneer globally, Innovation Norway launched The Explorer – a marketplace promoting green technology.
Contract for phase IIb study in psoriasis
Arctic Bioscience signs 3-year agreement worth 75 million NOK with Smerud Medical Research International to conduct clinical study on psoriasis
Arctic Bioscience lists on Euronext Growth Oslo
A milestone has today been reached, as Arctic Bioscience’s shares has been admitted to trading on Euronext Growth.
Arctic Bioscience AS: NOK 300 million Private Placement successfully placed
Arctic Bioscience is pleased to announce that the Private Placement has been successfully placed.
Arctic Bioscience announces private placement and intention to list on Euronext Growth Oslo
Arctic Bioscience AS is contemplating a private placement raising gross proceeds of NOK 250 million and admission to trading on Euronext Growth Oslo.
Arctic Nutrition changes company name to Arctic Bioscience
The new company name Arctic Bioscience marks a strategic shift from developing dietary supplements to also developing pharmaceutical products.
Arctic Nutrition is officially a member of the Life Science Cluster
The Life Science Cluster is the perfect arena for collaboration and knowledge-transfer.
SIVA award 2020 goes to Arctic Nutrition AS
Minister of Trade, Iselin Nybø, awarded Arctic Nutrition the SIVA Award 2020.
